SALIX PHARMACEUTICALS LTD Indenture Agreements

7 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
First Supplemental Indenture to 1.5% Convertible Senior Notes due 2019 between Salix Pharmaceuticals, Ltd. and U.S. Bank National Association
Indenture Agreements
SALIX PHARMACEUTICALS LTD
Pharmaceuticals
NY
2015
First Supplemental Indenture to 2.75% Convertible Senior Notes due 2015 between Salix Pharmaceuticals, Ltd. and U.S. Bank National Association
Indenture Agreements
SALIX PHARMACEUTICALS LTD
Pharmaceuticals
NY
2015
Supplemental Indenture to 6.00% Senior Notes Due 2021—Salix Pharmaceuticals, Ltd. and Subsidiaries with U.S. Bank National Association as Trustee
Indenture Agreements
SALIX PHARMACEUTICALS LTD
Pharmaceuticals
NY
2014
Indenture for 6.00% Senior Notes Due 2021 between Salix Pharmaceuticals, Ltd. and U.S. Bank National Association
Indenture Agreements
SALIX PHARMACEUTICALS LTD
Pharmaceuticals
DE
2013
Indenture Agreement for 1.5% Convertible Senior Notes due 2019 between Salix Pharmaceuticals, Ltd. and U.S. Bank National Association
Indenture Agreements
SALIX PHARMACEUTICALS LTD
Pharmaceuticals
DE
2012
First Supplemental Indenture between Salix Pharmaceuticals, Ltd. and U.S. Bank National Association (March 14, 2012)
Indenture Agreements
SALIX PHARMACEUTICALS LTD
Pharmaceuticals
NY
2012
Indenture Agreement for 5.5% Convertible Senior Notes due 2028 between Salix Pharmaceuticals, Ltd. and U.S. Bank National Association
Indenture Agreements
SALIX PHARMACEUTICALS LTD
Pharmaceuticals
DE
2008